Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available.
about
A review of quality of life instruments used in liver transplantationUse of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseasesClinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment.Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE studyCost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: Adjusting for the burden of ensuing chronic kidney diseaseImprovements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled studyAssessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease.Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis.Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36Methods and issues associated with the use of quality-adjusted life-years.Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire.Good practice guidelines for the use of statistical regression models in economic evaluations.Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study.Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.Predicting preference-based SF-6D index scores from the SF-8 health survey.The Cost-Effectiveness of Anterior Cruciate Ligament Reconstruction in Competitive Athletes.Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease.Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey.Short-form 6D assessment in compression module of the American College of Phlebology Patient Reported Outcome Venous Registry.A pilot test of a peer navigator intervention for improving the health of individuals with serious mental illness.Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.The Use of Mapping to Estimate Health State Utility Values.Quality of life along the diabetes continuum: a cross-sectional view of health-related quality of life and general health status in middle-aged and older Finns.Coronary bypass surgery versus percutaneous coronary intervention: cost-effectiveness in Iran: a study in patients with multivessel coronary artery disease.Cost-effectiveness of screening forHLA-A*31:01prior to initiation of carbamazepine in epilepsyThe Patient-Reported Outcomes Thermometer–5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases
P2860
Q33506217-A45A9845-0D68-453E-A7C7-26B3BCFE78DEQ33515869-09870CA1-2D0F-42B4-8664-602BC84CFCF8Q35030613-1AE87CFC-8C10-4CC3-B4A5-699262B50E7AQ36033361-212EB53C-00E7-4018-AFED-3E7DE110D86CQ36252760-9669A67E-DAFD-4E78-9440-580EE00EDA73Q36833762-1A8C16BE-F4BB-4C3C-A9FD-7C304C76B002Q36866954-319AD351-92C7-4411-ACDB-C6213CD59363Q37236384-08A35F6B-AFBB-45B6-AA34-ACDAB1854007Q37236947-12C9FACA-4B32-4EB4-9122-9D437E7F2C98Q37725041-369190F7-B6C8-438A-931A-ACA1ABDBBF42Q37978909-5F96D01E-CB5F-4954-B24B-BDC99462FA36Q38068462-6EF1B914-4F38-4A85-8714-F6CEA906960DQ38117585-1A664667-7292-4F0B-BE2F-F77B481FD8EFQ38412511-6D810ED7-3F31-4EDA-80C6-7A166B1D4EA6Q39159788-95E2E5C1-3003-4DFF-BC0C-F5BF2B97E133Q39538688-C875FEFF-A432-4C9E-9B47-BA87D5D3B39AQ40596585-C4101A8F-018E-4C26-94A8-3DADFBD6681AQ43871649-D5D80AE1-45A6-46E2-B78B-765340F6AF12Q43937776-83144013-3574-4A7E-8606-9E9F5D8070C7Q45330767-78629828-853E-44C8-9226-6AA5DC637439Q46081145-01FB3820-7967-4439-9645-AD1A7DE9317AQ46099151-2DB68D3A-82A8-4991-A2C3-BB1A37449FBCQ46423249-199AB01D-16C6-4822-AFD4-271E1221BEDAQ47755831-715DF85F-6EFC-4B9B-9D5D-3D139D46C456Q48086226-25AD3CCC-90CA-4225-8C85-631B2B5A59BEQ51034959-AD094FB2-BA61-42FD-A4D9-32110B19BC22Q57302557-23BF2DEA-3819-405D-B724-07050CA439AEQ58697954-DED75654-8DBE-40B9-84AC-6B5B0DB3036B
P2860
Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Predicting the short form-6D p ...... level data are not available.
@ast
Predicting the short form-6D p ...... level data are not available.
@en
type
label
Predicting the short form-6D p ...... level data are not available.
@ast
Predicting the short form-6D p ...... level data are not available.
@en
prefLabel
Predicting the short form-6D p ...... level data are not available.
@ast
Predicting the short form-6D p ...... level data are not available.
@en
P1433
P1476
Predicting the short form-6D p ...... level data are not available.
@en
P2093
John Brazier
Roberta Ara
P304
P356
10.1111/J.1524-4733.2008.00428.X
P577
2008-07-18T00:00:00Z